PET synthesis platform F300E

radiochemistry

This device is designed to synthesize 18F-FDG, a radiopharmaceutical used in the detection of glucose level for the diagnosis of malignant tumors and the level of myocardial glucose metabolism function; the determination of the area of glucose metabolism abnormality at the core of metastasis; and the imaging of inflammation sites for the diagnosis of macrovasculitis. Features 1 Best seller FDG dedicated synthesizer 2 Easy & quick operation with a disposable cassette 3 High Radiochemical Yield (65 +/- 5% EOS) 4 Auto-cleaning function